Youmanitarian
11 Jun 2021
Olaparib in Ovarian Cancer
16 vistas
TAKE ACTION
Donations would go to support charities for
Cómo hacer y estilo
In this segment, Bradley J. Monk, MD; Robert L. Coleman, MD; and Angeles Alvarez Secord, MD, examine the role of poly-ADP ribose polymerase (PARP) inhibitor, olaparib, in the treatment of advanced ovarian cancer.
Mostrar más
More ways to take action
Explore ways that you can help bring a solution to this issue.
Create Youms with hashtags Cómo hacer y estilo
Create a challenge to bring awareness to this issue for people to complete
Create a fundraiser to support a charity that tackle this issue
Volunteer at charitable organization that support this cause
Create a movement page dedicated to this cause to bring awareness.
Start a uCharity for this cause and invite people to join it to support this cause
